FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluconazole by Rising Pharma Holdings, Inc., authorizing an updated generic product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Cryptococcal Meningitis
• Cryptococcosis
• Esophageal Candidiasis
• Invasive Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)